chr8-22002914-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001100161.2(XPO7):c.2971-305T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001100161.2 intron
Scores
Clinical Significance
Conservation
Publications
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001100161.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| XPO7 | NM_015024.5 | MANE Select | c.2944-305T>C | intron | N/A | NP_055839.3 | |||
| XPO7 | NM_001100161.2 | c.2971-305T>C | intron | N/A | NP_001093631.1 | ||||
| XPO7 | NM_001362802.2 | c.2878-305T>C | intron | N/A | NP_001349731.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| XPO7 | ENST00000252512.14 | TSL:1 MANE Select | c.2944-305T>C | intron | N/A | ENSP00000252512.9 | |||
| XPO7 | ENST00000433566.8 | TSL:5 | c.2947-305T>C | intron | N/A | ENSP00000410249.3 | |||
| XPO7 | ENST00000879832.1 | c.2923-305T>C | intron | N/A | ENSP00000549891.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 64980Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 34062
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at